SCHEDULE: Beryl Capital Exits Vigil Neuroscience Stake

Sentiment:

Beneficial Ownership Amendment 14 November 2025 2:32 PM

📋All filings for Vigil Neuroscience, INC

Beryl Capital Management and its affiliates have fully divested their beneficial ownership in Vigil Neuroscience, Inc., reporting 0% ownership.

Worse than expectedA significant institutional investor, Beryl Capital Management, has fully divested its stake in Vigil Neuroscience, Inc., reducing its beneficial ownership to 0%. This indicates a loss of confidence or a strategic exit by a major holder.

Summary

Beryl Capital Management LLC, Beryl Capital Management LP, Beryl Capital Partners II LP, and David A. Witkin have filed an Amendment No. 1 to Schedule 13G.
The filing indicates that the reporting persons no longer beneficially own any shares of Vigil Neuroscience, Inc. Common Stock, reporting 0.00 shares and 0% of the class.
This amendment signifies a complete divestment of their previously reportable stake in Vigil Neuroscience, Inc.

Sentiment

Score: 2

Explanation: The complete divestment of a previously reportable stake by an institutional investor is generally a negative signal for the issuer, indicating a lack of confidence or a strategic shift away from the company.

Negatives

A significant institutional investor, Beryl Capital Management and its affiliates, has fully divested its stake in Vigil Neuroscience, Inc., reducing its ownership to 0%.

Future Outlook

The filing does not contain any forward-looking statements or guidance from Vigil Neuroscience, Inc. or the reporting persons regarding the issuer's future.

Industry Context

The divestment by Beryl Capital Management could be interpreted by the market as a change in sentiment or strategy by a notable institutional investor regarding Vigil Neuroscience, Inc. or the broader biotechnology sector, particularly in the context of neurological disorders.

Stakeholder Impact

Shareholders of Vigil Neuroscience, Inc. may view the complete divestment by Beryl Capital Management as a negative indicator, potentially influencing their investment decisions.
The market perception of Vigil Neuroscience, Inc. could be negatively impacted by the exit of a significant institutional investor.

Key Dates

Date	Description
09/30/2025	Date of event which required the filing of this statement (beneficial ownership dropped to 0%)
11/14/2025	Signature date of the filing by reporting persons

Recommendation

sell

The complete divestment of a significant stake by an institutional investor like Beryl Capital Management typically signals a lack of confidence in the company's future prospects or a strategic re-allocation of capital. This action by a sophisticated investor could prompt other investors to re-evaluate their positions, potentially leading to downward pressure on the stock price. Therefore, a 'sell' recommendation is warranted based on this significant negative signal.

Keywords

Vigil Neuroscience, Beryl Capital Management, Schedule 13G, Divestment, Institutional Ownership, Common Stock, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.